Four technologies to profile your AAVs

You need to profile your AAV vector to ensure you are developing an effective gene therapy delivery system. In this mini-guide, learn about 4 technologies that give you a full stability profile of your gene therapy vector. From serotype assessment, to monitoring aggregate formation, to checking vector purity, to evaluating capsid assembly and genetic fill — these  4 technologies will help you identify the best formulation and multi-parameter quality control of AAVs, so you build more effective gene therapy vectors.

Previous Article
5 benefits of optimizing your formulation buffer to get your AAV therapeutic approved
5 benefits of optimizing your formulation buffer to get your AAV therapeutic approved

As a gene therapy scientist, you face an abundance of challenges when working to build an effective AAV the...

Up next
How Merck KGaA uses light scattering measurements for better developability assessment of biologic therapeutics
How Merck KGaA uses light scattering measurements for better developability assessment of biologic therapeutics

Ready to tackle your challenging stability characterizations?

Discover tools